体重指数≥40患者全髋关节置换术:无BMI限制机构的结果
本研究回顾性分析单中心3577例初次全髋关节置换术,比较BMI<40与BMI≥40患者结局。BMI≥40组感染、重返手术室和翻修手术均更常见,BMI≥40独立预测重返手术室和感染。但该组合并症负担更重,提示风险受BMI与合并症共同影响,支持个体化选择。
要点
- BMI≥40患者感染率2.9%、重返手术室6.4%、翻修4.7%,均高于BMI<40组。
- BMI≥40独立预测重返手术室(HR 1.63)和感染(OR 2.94)。
- BMI 30-39.9与BMI<30相比未显示风险增加,风险主要由BMI≥40驱动。
核心结论
- 病态肥胖与全髋关节置换术后感染和重返手术室风险增加相关,但风险受BMI与合并症负担共同影响,支持个体化风险调整的患者选择和围术期优化。
研究设计与样本
- 回顾性 review,纳入2016年6月至2024年4月单学术中心3577例初次全髋关节置换术,按BMI<40(n=3169)和BMI≥40(n=408)分组。
- 采用多变量Cox和logistic回归分析,并进行三分类BMI(<30、30-39.9、≥40)的敏感性分析。
主要发现
- BMI≥40组更年轻,ASA 3-4级比例更高(83.1% vs 42.5%,P<0.01)。
- BMI≥40组感染率2.9% vs 1.1%(P<0.01),重返手术室6.4% vs 3.0%(P<0.01),翻修手术4.7% vs 2.2%(P<0.01)。
- BMI≥40独立预测重返手术室(HR 1.63,P=0.03)和感染(OR 2.94,P<0.01)。
- 敏感性分析显示围术期风险增加主要由BMI≥40组驱动,BMI 30-39.9与BMI<30相比风险未增加。
关键数值与推荐
- BMI≥40与重返手术室风险独立相关(HR 1.63,P=0.03)。
- BMI≥40与感染风险独立相关(OR 2.94,P<0.01)。
- BMI≥40组ASA 3-4级占83.1%,BMI<40组占42.5%(P<0.01)。
临床怎么用
- 对于BMI≥40患者,应充分评估合并症负担并加强围术期优化,而非仅依据BMI一刀切拒绝手术。
- BMI 30-39.9患者风险未显著增加,可参考常规围术期管理。
局限性
- 本研究为单中心回顾性设计,结果外推需谨慎。
- 原文未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Morbid obesity (body Mass Index [BMI] ≥ 40) has been associated with increased perioperative risk following total hip arthroplasty (THA), leading many institutions to impose strict BMI cutoffs. Our institution does not restrict THA based on BMI. METHODS: A retrospective review was conducted of 3,577 primary THAs performed between June 2016 and April 2024 at a single academic center. Patients were stratified by BMI less than 40 (n = 3,169) and BMI ≥ 40 (n = 408). Primary outcomes were return to the operating room (OR) and revision surgery. Secondary outcomes included infection and aseptic implant failure. Multivariable Cox and logistic regression analyses were performed, including a sensitivity analysis using three BMI categories (less than 30, 30 to 39.9, and ≥ 40). RESULTS: Patients who had a BMI ≥ 40 were younger, and had higher American Society of Anesthesiologists (ASA) classifications (83.1% ASA 3 to 4 versus 42.5%, P < 0.01). Infection (2.9 versus 1.1%, P < 0.01), return to OR (6.4 versus 3.0%, P < 0.01), and revision surgery (4.7 versus 2.2%, P < 0.01) were more common in the BMI ≥ 40 cohort. A body mass index ≥ 40 independently predicted return to OR (HR [hazard ratio] 1.63, P = 0.03) and infection (odds ratio [OR] 2.94, P < 0.01). Sensitivity analyses demonstrated that increased perioperative risk was primarily driven by the BMI ≥ 40 cohort, whereas BMI 30 to 39.9 was not associated with increased risk compared with BMI less than 30. CONCLUSIONS: Morbid obesity is associated with increased postoperative infection and return to the OR following THA. However, patients who had a BMI ≥ 40 demonstrated substantially greater medical complexity, suggesting that perioperative risk is influenced by both BMI and associated comorbidity burden. These findings support individualized, risk-adjusted patient selection and perioperative optimization.
引用
- Salazar C, Shankar V, Hanna A, et al. Total Hip Arthroplasty in Patients Who Have a Body Mass Index ≥ 40: Outcomes at an Institution Without Cutoffs. J Arthroplasty. 2026. PMID: 42600866. doi:10.1016/j.arth.2026.08.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。